Evidence map›Paper›PMID 27018545›Full record

ArticleTissue engineering. Part C, Methods2016

Customized Interface Biofunctionalization of Decellularized Extracellular Matrix: Toward Enhanced Endothelialization.

Hug Aubin, Carlos Mas-Moruno, Makoto Iijima, Nicolas Schütterle, Meike Steinbrink, Alexander Assmann, Francesc Javier Gil, Artur Lichtenberg, Marta Pegueroles, Payam Akhyari

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part C, Methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Systematic Review of Tissue-Engineered Vascular Grafts.Frontiers in bioengineering and biotechnology · 2021
    Review
  13. Review
  14. Article
  15. Article
  16. Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  17. Translational Challenges in Cardiovascular Tissue Engineering.Journal of cardiovascular translational research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Hug Aubin1 Department of Cardiovascular Surgery, Heinrich-Heine University Düsseldorf , Düsseldorf, Germany .
Carlos Mas-Moruno3 Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Metallurgical Engineering, Technical University of Catalonia (UPC) , Barcelona, Spain .
Makoto Iijima2 Research Group for Experimental Surgery, Department of Cardiovascular Surgery, Medical Faculty, Heinrich-Heine University Düsseldorf , Düsseldorf, Germany .
Nicolas Schütterle2 Research Group for Experimental Surgery, Department of Cardiovascular Surgery, Medical Faculty, Heinrich-Heine University Düsseldorf , Düsseldorf, Germany .
Meike Steinbrink2 Research Group for Experimental Surgery, Department of Cardiovascular Surgery, Medical Faculty, Heinrich-Heine University Düsseldorf , Düsseldorf, Germany .
Alexander Assmann1 Department of Cardiovascular Surgery, Heinrich-Heine University Düsseldorf , Düsseldorf, Germany .
Francesc Javier Gil3 Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Metallurgical Engineering, Technical University of Catalonia (UPC) , Barcelona, Spain .
Artur Lichtenberg1 Department of Cardiovascular Surgery, Heinrich-Heine University Düsseldorf , Düsseldorf, Germany .
Marta Pegueroles3 Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Metallurgical Engineering, Technical University of Catalonia (UPC) , Barcelona, Spain .
Payam Akhyari1 Department of Cardiovascular Surgery, Heinrich-Heine University Düsseldorf , Düsseldorf, Germany .
Heinrich Heine University Düsseldorf · DEUniversitat Politècnica de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interface biofunctionalization strategies try to enhance and control the interaction between implants and host organism. Decellularized extracellular matrix (dECM) is widely used as a platform for bioengineering of medical implants, having shown its suitability in a variety of preclinical as well as clinical models. In this study, specifically designed, custom-made synthetic peptides were used to functionalize dECM with different cell adhesive sequences (RGD, REDV, and YIGSR). Effects on in vitro endothelial cell adhesion and in vivo endothelialization were evaluated in standardized models using decellularized ovine pulmonary heart valve cusps (dPVCs) and decellularized aortic grafts (dAoGs), respectively. Contact angle measurements and fluorescent labeling of custom-made peptides showed successful functionalization of dPVCs and dAoGs. The functionalization of dPVCs with a combination of bioactive sequences significantly increased in vitro human umbilical vein endothelial cell adhesion compared to nonfunctionalized controls. In a functional rodent aortic transplantation model, fluorescent-labeled peptides on dAoGs were persistent up to 10 days in vivo under exposure to systemic circulation. Although there was a trend toward enhanced in vivo endothelialization of functionalized grafts compared to nonfunctionalized controls, there was no statistical significance and a large biological variability in both groups. Despite failing to show a clear biological effect in the used in vivo model system, our initial findings do suggest that endothelialization onto dECM may be modulated by customized interface biofunctionalization using the presented method. Since bioactive sequences within the dECM-synthetic peptide platform are easily interchangeable and combinable, further control of host cell proliferation, function, and differentiation seems to be feasible, possibly paving the way to a new generation of multifunctional dECM scaffolds for regenerative medicine.

Indexed as

AnimalsCell AdhesionCell DifferentiationCell ProliferationCells, CulturedExtracellular MatrixHeart ValvesHumansHuman Umbilical Vein Endothelial CellsMalePulmonary ValveRatsRats, WistarSheepTissue EngineeringTissue Scaffolds

Identifiers

PMID27018545
PMCPMC4870611
OpenAlexW2342824301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.